Einat Brill Almon Insider Trading $PLX Protalix BioTherapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Einat Brill Almon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Einat Brill Almon. Einat Brill Almon is VP, Product Development in Protalix BioTherapeutics, Inc. ($PLX).
Einat Brill Almon in Protalix BioTherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Einat Brill Almon: VP, Product Development
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 06 2010
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Einat Brill Almon in Protalix BioTherapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 06 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | M | 0.97 | 70,000 | 68,040 | 116,848 | |
| Oct 06 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Buy | M | 0.97 | 70,000 | 68,040 | 0 | -70,000 to 0 (-100.00 %) |
| Oct 06 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 9.29 | 15,000 | 139,350 | 0 | 15 K to 0 (-100.00 %) |
| Oct 06 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 9.08 | 20,000 | 181,600 | 0 | 20 K to 0 (-100.00 %) |
| Oct 06 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 9.02 | 35,000 | 315,700 | 0 | 35 K to 0 (-100.00 %) |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | M | 0.97 | 45,260 | 43,993 | 186,848 | |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | M | 0.40 | 4,740 | 1,891 | 0 | |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Buy | M | 0.97 | 45,260 | 43,993 | 0 | -45,260 to 0 (-100.00 %) |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Buy | M | 0.40 | 4,740 | 1,891 | 0 | -4,740 to 0 (-100.00 %) |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 8.16 | 22,500 | 183,600 | 0 | 22.5 K to 0 (-100.00 %) |
| Sep 08 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 8.00 | 27,500 | 220,000 | 0 | 27.5 K to 0 (-100.00 %) |
| Feb 26 2010 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | A | 6.90 | 130,000 | 897,000 | 130,000 | |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | M | 0.40 | 93,954 | 37,488 | 4,740 | |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Payment of Exercise | F | 9.48 | 3,954 | 37,484 | 0 | 4 K to 0 (-100.00 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Buy | M | 0.40 | 93,954 | 37,488 | 0 | -93,954 to 0 (-100.00 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 9.43 | 38,320 | 361,358 | 0 | 38.3 K to 0 (-100.00 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 9.39 | 23,680 | 222,355 | 0 | 23.7 K to 0 (-100.00 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 9.39 | 28,000 | 262,920 | 0 | 28 K to 0 (-100.00 %) |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | M | 0.40 | 59,822 | 23,869 | 98,694 | |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Payment of Exercise | F | 4.95 | 4,822 | 23,869 | 0 | 4.8 K to 0 (-100.00 %) |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Buy | M | 0.40 | 59,822 | 23,869 | 0 | -59,822 to 0 (-100.00 %) |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 4.95 | 11,000 | 54,450 | 0 | 11 K to 0 (-100.00 %) |
| Jul 08 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 5.13 | 44,000 | 225,720 | 0 | 44 K to 0 (-100.00 %) |
| May 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | M | 0.40 | 44,707 | 17,838 | 158,516 | |
| May 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Sell | S | 4.00 | 40,000 | 160,000 | 0 | 40 K to 0 (-100.00 %) |
| May 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Payment of Exercise | F | 3.79 | 4,707 | 17,840 | 40,000 | 44.7 K to 40 K (-10.53 %) |
| May 19 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Buy | M | 0.40 | 44,707 | 17,838 | 44,707 | 0 to 44.7 K |
| Feb 27 2009 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | A | 2.65 | 50,000 | 132,500 | 50,000 | |
| Feb 13 2008 | PLX | Protalix BioTherap ... | Almon Einat Brill | VP, Product Develop ... | Option Exercise | A | 5.00 | 311,272 | 1,556,360 | 311,272 |
Page: 1